​

Telomir Pharmaceuticals Ownership | Who Owns Telomir Pharmaceuticals?

OverviewFinancialsChart

Telomir Pharmaceuticals Ownership Summary

Telomir Pharmaceuticals is owned by 12.41% institutional investors, 34.17% insiders, and 53.42% retail investors. Legal & general group is the largest institutional shareholder, holding 0% of TELO shares.

TELO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTelomir Pharmaceuticals12.41%34.17%53.42%
SectorHealthcare Stocks 279.42%10.64%-190.05%
IndustryBiotech Stocks 64.05%10.69%25.27%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Legal & general group---
New york state common retirement fund---
Beaird harris wealth management---
Mirae asset global etfs---
Ameritas investment partners---
Rhumbline advisers---
Hightower advisors---
Gotham asset management---
Amalgamated bank---
Virtu financial---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Legal & general group---
New york state common retirement fund---
Beaird harris wealth management---
Mirae asset global etfs---
Ameritas investment partners---
Rhumbline advisers---
Hightower advisors---
Gotham asset management---
Amalgamated bank---
Virtu financial---

Top Buyers

HolderShares% AssetsChange
Russell investments group---104.00
Sterling capital management---148.00
Ameritas investment partners---471.00
Amalgamated bank---667.00
Legal & general group---1.94K

Top Sellers

HolderShares% AssetsChange
Charles schwab investment management---46.41K
Hightower advisors---43.00K
Virtu financial---14.96K
Atom investors lp---14.66K
Beaird harris wealth management---14.62K

Sold Out

HolderChange
Russell investments group-104.00
Sterling capital management-148.00
Ameritas investment partners-471.00
Amalgamated bank-667.00
Legal & general group-1.94K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20254213.51%3,694,1737.09%129.12%21-32.26%14-
Dec 31, 20243815.15%3,565,51874.27%1225.25%3239.13%--100.00%
Sep 30, 20243332.00%2,045,931465.97%6463.57%234.55%5150.00%
Jun 30, 202425257.14%361,492352.33%11473.94%22214.29%2-
Mar 31, 20247-79,917---7---

Insider Transactions Trends

DateBuySell
2025 Q2--
2024 Q4--
2024 Q3--

TELO Ownership FAQ

Who Owns Telomir Pharmaceuticals?

Telomir Pharmaceuticals shareholders are primarily institutional investors at 12.41%, followed by 34.17% insiders and 53.42% retail investors. The average institutional ownership in Telomir Pharmaceuticals's industry, Biotech Stocks , is 64.05%, which Telomir Pharmaceuticals falls below.

Who owns the most shares of Telomir Pharmaceuticals?

Telomir Pharmaceuticals’s largest shareholders are Legal & general group (0 shares, 0%), New york state common retirement fund (0 shares, 0%), and Beaird harris wealth management (0 shares, 0%). Together, they hold 0% of Telomir Pharmaceuticals’s total shares outstanding.

Does Blackrock own Telomir Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Telomir Pharmaceuticals.

Who is Telomir Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Legal & general group is Telomir Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Telomir Pharmaceuticals shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools